
pmid: 35971322
handle: 20.500.11768/131556 , 11573/1683615 , 11584/346857 , 11567/1103155 , 20.500.11769/548382 , 2158/1301721 , 11381/2936762 , 11586/409222
pmid: 35971322
handle: 20.500.11768/131556 , 11573/1683615 , 11584/346857 , 11567/1103155 , 20.500.11769/548382 , 2158/1301721 , 11381/2936762 , 11586/409222
Background: Definitions for reliable identification of transition from relapsing-remitting multiple sclerosis (MS) to secondary progressive (SP)MS in clinical cohorts are not available. Objectives: To compare diagnostic performances of two different data-driven SPMS definitions. Methods: Data-driven SPMS definitions based on a version of Lorscheider’s algorithm (DDA) and on the EXPAND trial inclusion criteria were compared, using the neurologist’s definition (ND) as gold standard, in terms of sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), Akaike information criterion (AIC) and area under the curve (AUC). Results: A cohort of 10,240 MS patients with ⩾5 years of follow-up was extracted from the Italian MS Registry; 880 (8.5%) patients were classified as SPMS according to the neurologist definition, 1806 (17.6%) applying the DDA and 1134 (11.0%) with the EXPAND definition. The DDA showed greater discrimination power (AUC: 0.8 vs 0.6) and a higher sensitivity (77.1% vs 38.0%) than the EXPAND definition, with similar specificity (88.0% vs 91.5%). PPV and NPV were higher using the DDA than considering EXPAND definition (37.5% vs 29.5%; 97.6% vs 94.0%). Conclusion: Data-driven definitions demonstrated greater ability to capture SP transition than neurologist’s definition and the global accuracy of DDA seems to be higher than the EXPAND definition.
Multiple Sclerosis, 610, Multiple Sclerosis, Chronic Progressive, Multiple sclerosis, Multiple Sclerosis, Relapsing-Remitting, big data, Area Under Curve, big data; data-driven algorithm; disease registry; Multiple sclerosis; prognosis; secondary progressive, data-driven algorithm, disease registry, secondary progressive, Humans, Multiple sclerosi, prognosis, Multiple sclerosis; big data; data-driven algorithm; disease registry; prognosis; secondary progressive, prognosi
Multiple Sclerosis, 610, Multiple Sclerosis, Chronic Progressive, Multiple sclerosis, Multiple Sclerosis, Relapsing-Remitting, big data, Area Under Curve, big data; data-driven algorithm; disease registry; Multiple sclerosis; prognosis; secondary progressive, data-driven algorithm, disease registry, secondary progressive, Humans, Multiple sclerosi, prognosis, Multiple sclerosis; big data; data-driven algorithm; disease registry; prognosis; secondary progressive, prognosi
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 9 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
